AntihypoxamiR functionalized gramicidin lipid nanoparticles rescue against ischemic memory improving cutaneous wound healing

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 7, 2016, Pages 1827-1831

  Ghatak, Subhadip ^a   Li, Jilong ^b   Chan, Yuk C ^a   Gnyawali, Surya C ^a   Steen, Erin ^a   Yung, Bryant C ^b   Khanna, Savita ^a   Roy, Sashwati ^a   Lee, Robert J ^b   Sen, Chandan K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Ischemic wounds; Keratinocytes proliferation; Lipid nanoparticles; MiR 210; Tissue oxygenation

Indexed keywords

BIOCHEMISTRY; CELL PROLIFERATION; NANOPARTICLES;

ISCHEMIC WOUNDS; KERATINOCYTES; LIPID NANOPARTICLES; MIR-210; TISSUE OXYGENATION;

TISSUE;

ADENOSINE TRIPHOSPHATE; ANTIHYPOXAMIR FUNCTIONALIZED GRAMICIDIN LIPID NANOPARTICLE; GRAMICIDIN; KI 67 ANTIGEN; LOCKED NUCLEIC ACID; MICRORNA 210; NANOPARTICLE; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; ANTIINFECTIVE AGENT; LIPID; MICRORNA;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CELL PROLIFERATION; CHRONIC WOUND; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EPIDERMIS CELL; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOREACTIVITY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NANOENCAPSULATION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; WOUND CLOSURE; WOUND HEALING; ANIMAL; ISCHEMIA; METABOLISM;

ANIMALS; ANTI-BACTERIAL AGENTS; GRAMICIDIN; HUMANS; ISCHEMIA; KERATINOCYTES; LIPIDS; MICE; MICRORNAS; NANOPARTICLES; WOUND HEALING;

EID: 84973463350     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2016.03.004     Document Type: Article

References (16)

1. Sen C.K. Wound healing essentials: Let there be oxygen. Wound Repair Regen 2009, 17:1-18.
2. Biswas S., Roy S., Banerjee J., Hussain S.R., Khanna S., Meenakshisundaram G., et al. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci U S A 2010, 107:6976-6981.
3. Chan Y.C., Banerjee J., Choi S.Y., Sen C.K. miR-210: The master hypoxamir. Microcirculation 2012, 19:215-223.
4. Sen C.K., Roy S. OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol 2012, 23:971-980.
5. Woo K.Y. Assessing Chronic Wound Perfusion in the Lower Extremity: Current and Emerging Approaches 2015.
6. Sen C.K., Roy S. Oxygenation state as a driver of myofibroblast differentiation and wound contraction: Hypoxia impairs wound closure. J Invest Dermatol 2010, 130:2701-2703.
7. Ghatak S., Chan Y.C., Khanna S., Banerjee J., Weist J., Roy S., et al. Barrier function of the repaired skin is disrupted following arrest of dicer in keratinocytes. Mol Ther 2015, 23:1201-1210.
8. Underwood R.A., Carter W.G., Usui M.L., Olerud J.E. Ultrastructural localization of integrin subunits beta4 and alpha3 within the migrating epithelial tongue of in vivo human wounds. J Histochem Cytochem 2009, 57:123-142.
9. Campbell C.S., Contreras-Rojas L.R., Delgado-Charro M.B., Guy R.H. Objective assessment of nanoparticle disposition in mammalian skin after topical exposure. J Control Release 2012, 162:201-207.
10. Watkinson A.C., Bunge A.L., Hadgraft J., Lane M.E. Nanoparticles do not penetrate human skin - a theoretical perspective. Pharm Res 2013, 30:1943-1946.
11. Nie S. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond, Engl) 2010, 5:523-528.
12. Mura S., Nicolas J., Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater 2013, 12:991-1003.
13. Zhang M., Zhou X., Wang B., Yung B.C., Lee L.J., Ghoshal K., et al. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J Control Release 2013, 168:251-261.
14. Porteous D.J., Dorin J.R., McLachlan G., Davidson-Smith H., Davidson H., Stevenson B.J., et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 1997, 4:210-218.
15. Chang H.-I., Yeh M.-K. Clinical development of liposome-based drugs: Formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 2012, 7:49-60.
16. Guo Y., Luo J., Tan S., Otieno B.O., Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 2013, 49:175-186.